| Financial Year |
March 31 2023 |
| Monetary Funds |
153,247,831.55 |
| Held-for-trading Financial Assets |
119,124,432.36 |
| Notes Receivable |
781,969.77 |
| Accounts Receivable |
145,027,273.53 |
| Advances to Suppliers |
1,561,821.56 |
| Other Receivables |
76,607,844.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
34,635,740.33 |
| Total Current Assets |
535,852,232.63 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
34,598,735.99 |
| Investment Properties |
-- |
| Fixed Assetes |
93,858,136.86 |
| Under-construction Projects |
1,387,262.20 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
11,519,935.97 |
| R&D expenses |
1,124,292.61 |
| Goodwill |
239,956,440.94 |
| Long-Term Deferred and Prepaid Expenses |
9,551,444.77 |
| Deferred Income Tax Assets |
7,729,969.13 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
421,141,714.29 |
| Total Assets |
956,993,946.92 |
| Short-Term Loans |
34,800,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
61,685,479.79 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,599,744.44 |
| Taxes Payable |
7,328,832.02 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
52,521,703.64 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,718,971.55 |
| Other Current Liabilities |
245,296.76 |
| Sub-Total of Current Liabilities |
168,922,586.70 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,553,582.61 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
19,431,371.93 |
| Total Liabilities |
188,353,958.63 |
| Paid-In Capital(Or Share Stock) |
109,969,792.00 |
| Capital Surplus |
342,612,365.92 |
| Surplus Reserve |
22,945,716.31 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
217,774,997.12 |
| Minority Stockholder's Interest |
85,320,018.13 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
683,319,970.16 |
| Owner's Equity（Stockholder's Equity） |
768,639,988.29 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
956,993,946.92 |
